Theriva Biologics, Inc. (TOVX)
0.2411
0.00 (0.00%)
USD |
NYAM |
Jun 10, 16:00
0.2288
-0.01
(-5.10%)
After-Hours: 20:00
Theriva Biologics EPS Diluted (Quarterly) : -0.0498 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.0498 |
| December 31, 2025 | -0.0982 |
| September 30, 2025 | -0.4507 |
| June 30, 2025 | -1.934 |
| March 31, 2025 | -1.554 |
| December 31, 2024 | -1.598 |
| September 30, 2024 | -6.811 |
| June 30, 2024 | -10.72 |
| March 31, 2024 | -7.53 |
| December 31, 2023 | -7.996 |
| September 30, 2023 | -4.845 |
| June 30, 2023 | -8.380 |
| March 31, 2023 | -7.402 |
| December 31, 2022 | -8.886 |
| September 30, 2022 | -7.621 |
| June 30, 2022 | -7.065 |
| March 31, 2022 | -7.73 |
| December 31, 2021 | -9.965 |
| September 30, 2021 | -6.198 |
| June 30, 2021 | -6.05 |
| March 31, 2021 | -31.55 |
| December 31, 2020 | -36.21 |
| September 30, 2020 | -34.62 |
| June 30, 2020 | -45.12 |
| March 31, 2020 | -50.16 |
| Date | Value |
|---|---|
| December 31, 2019 | -46.74 |
| September 30, 2019 | -78.14 |
| June 30, 2019 | -56.32 |
| March 31, 2019 | -63.41 |
| December 31, 2018 | -277.41 |
| September 30, 2018 | -232.17 |
| June 30, 2018 | -289.01 |
| March 31, 2018 | -161.61 |
| December 31, 2017 | 175.00 |
| September 30, 2017 | -1225.00 |
| June 30, 2017 | -262.50 |
| March 31, 2017 | -175.00 |
| December 31, 2016 | -175.00 |
| September 30, 2016 | -787.50 |
| June 30, 2016 | -875.00 |
| March 31, 2016 | -1050.00 |
| December 31, 2015 | -1050.00 |
| September 30, 2015 | -1050.00 |
| June 30, 2015 | -1662.50 |
| March 31, 2015 | -1487.50 |
| December 31, 2014 | -875.00 |
| September 30, 2014 | -700.00 |
| June 30, 2014 | -700.00 |
| March 31, 2014 | -612.50 |
| December 31, 2013 | -787.50 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Savara, Inc. | -0.1472 |
| Vericel Corp. | -0.1241 |
| Biogen, Inc. | 2.153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.044M |
| Revenue (Quarterly) | 0.30M |
| Total Expenses (Quarterly) | 2.344M |
| Enterprise Value | 0.3543M |
| Gross Profit Margin (Quarterly) | 92.00% |
| Profit Margin (Quarterly) | -681.3% |
| Earnings Yield | -1.05K% |
| Normalized Earnings Yield | -662.96 |